Molecularly targeted therapies in cervical cancer. A systematic review

F Zagouri, TN Sergentanis, D Chrysikos, M Filipits… - Gynecologic …, 2012 - Elsevier
Cervical cancer represents the third most common cause of female cancer mortality. Even
with the best currently available treatment, a significant proportion of patients will experience …

Molecularly targeted therapies in cervical cancer. A systematic review

F Zagouri, TN Sergentanis, D Chrysikos, M Filipits… - Gynecologic …, 2012 - infona.pl
Cervical cancer represents the third most common cause of female cancer mortality. Even
with the best currently available treatment, a significant proportion of patients will experience …

[引用][C] Molecularly targeted therapies in cervical cancer. A systematic review

F Zagouri, TN Sergentanis, D Chrysikos, M Filipits… - Gynecologic …, 2012 - cir.nii.ac.jp
Molecularly targeted therapies in cervical cancer. A systematic review | CiNii Research CiNii
国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …

Molecularly targeted therapies in cervical cancer. A systematic review.

F Zagouri, TN Sergentanis, D Chrysikos… - Gynecologic …, 2012 - europepmc.org
Cervical cancer represents the third most common cause of female cancer mortality. Even
with the best currently available treatment, a significant proportion of patients will experience …

Molecularly targeted therapies in cervical cancer. A systematic review

F Zagouri, TN Sergentanis, D Chrysikos… - Gynecologic …, 2012 - pubmed.ncbi.nlm.nih.gov
Cervical cancer represents the third most common cause of female cancer mortality. Even
with the best currently available treatment, a significant proportion of patients will experience …

Molecularly targeted therapies in cervical cancer. A systematic review

F Zagouri, TN Sergentanis… - Gynecologic …, 2012 - gynecologiconcology-online.net
Cervical cancer represents the third most common cause of female cancer mortality. Even
with the best currently available treatment, a significant proportion of patients will experience …